|
Kanemaru, Kelli K; Tuthill, Matthew C; Takeuchi, Kenneth K et al. (2008) Retinoic acid induced downregulation of MYCN is not mediated through changes in Sp1/Sp3. Pediatr Blood Cancer 50:806-11
|
|
Tuthill, Matthew C; Wada, Randal K; Arimoto, Jason M et al. (2003) N-myc oncogene expression in neuroblastoma is driven by Sp1 and Sp3. Mol Genet Metab 80:272-80
|
|
Sidell, N; Pasquali, M; Malkapuram, S et al. (2003) In vitro and in vivo effects of easily administered, low-toxic retinoid and phenylacetate compounds on human neuroblastoma cells. Br J Cancer 89:412-9
|
|
Fan, L; Iyer, J; Zhu, S et al. (2001) Inhibition of N-myc expression and induction of apoptosis by iron chelation in human neuroblastoma cells. Cancer Res 61:1073-9
|
|
Han, S; Wada, R K; Sidell, N (2001) Differentiation of human neuroblastoma by phenylacetate is mediated by peroxisome proliferator-activated receptor gamma. Cancer Res 61:3998-4002
|
|
Han, S W; Greene, M E; Pitts, J et al. (2001) Novel expression and function of peroxisome proliferator-activated receptor gamma (PPARgamma) in human neuroblastoma cells. Clin Cancer Res 7:98-104
|
|
Sidell, N; Sawatsri, S; Connor, M J et al. (2000) Pharmacokinetics of chronically administered all-trans-retinoyl-beta-glucuronide in mice. Biochim Biophys Acta 1502:264-72
|
|
Sidell, N; Chang, B; Yamashiro, J M et al. (1998) Transcriptional upregulation of retinoic acid receptor beta (RAR beta) expression by phenylacetate in human neuroblastoma cells. Exp Cell Res 239:169-74
|
|
Wada, R K; Pai, D S; Huang, J et al. (1997) Interferon-gamma and retinoic acid down-regulate N-myc in neuroblastoma through complementary mechanisms of action. Cancer Lett 121:181-8
|
|
Goodman, L A; Liu, B C; Thiele, C J et al. (1997) Modulation of N-myc expression alters the invasiveness of neuroblastoma. Clin Exp Metastasis 15:130-9
|
Showing the most recent 10 out of 11 publications
